ONCY

#3917
Oncolytics Biotech, Inc. Common Shares
1.04 USD
+1.96%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.04
1.05
Rango anual
0.33
1.51
Cambio diario
+1.96%
Variación mensual
+5.05%
Variación en los últimos 6 meses
-14.75%
Cambio anual
+79.31%
Cierres anteriores
1.02
Abrir
1.04
Bid
Ask
Mínimo
1.04
High
1.05
Volumen
57
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Noticias